NCT01712711View on ClinicalTrials.gov

Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

March 31, 2013

Conditions
Non-alcoholic Fatty Liver Disease
Interventions
DRUG

H.pylori eradication

The regimen consists of Omeprazole (20 mg/BD)+ Amoxicillin (1 g/day)+ Bismuth subcitrate (240 mg/BD)+ Azithromycin (500 mg/BD)for two weeks

Trial Locations (1)

Unknown

Gastroenterology clinic, Sina Hospital, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT01712711 - Helicobacter Pylori Eradication in Diabetic Subjects With Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter